Active Implants Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement

Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant.

The single-arm, prospective, open-label, non-randomized observational trial will enroll 20 patients with persistent knee pain caused by injured or deteriorating meniscus cartilage, at up to 20 U.S. sites.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us